Mice Lacking Gpr75 are Hypophagic and Thin

References

• Afshin A, Forouzanfar MH, Reitsma MB, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.
   PubMed Web of Science ®Google Scholar
• Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118:1723–1735. doi:10.1161/CIRCRESAHA.115.306825
   PubMed Web of Science ®Google Scholar
• Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14:435. doi:10.3390/ijerph14040435
   PubMed Web of Science ®Google Scholar
• Pillon NJ, Loos RJF, Marshall SM, Zierath JR. Metabolic consequences of obesity and type 2 diabetes: balancing genes and environment for personalized care. Cell. 2021;184:1530–1544. doi:10.1016/j.cell.2021.02.012
   PubMed Web of Science ®Google Scholar
• Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197–206. doi:10.1038/nature14177
   PubMed Web of Science ®Google Scholar
• Yang J, Bakshi A, Zhu Z, et al. Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat Genet. 2015;47:1114–1120. doi:10.1038/ng.3390
   PubMed Web of Science ®Google Scholar
• van der Klaauw AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161:119–132. doi:10.1016/j.cell.2015.03.008
   PubMed Web of Science ®Google Scholar
• Powell DR, Revelli J-P, Doree DD, et al. High-throughput screening of mouse gene knockouts identifies established and novel high body fat phenotypes. Diabetes Metab Syndr Obes. 2021;14:3753–3785. doi:10.2147/DMSO.S322083
   Web of Science ®Google Scholar
• Akiyama M, Okada Y, Kanai M, et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat Genet. 2017;49:1458–1467. doi:10.1038/ng.3951
   PubMed Web of Science ®Google Scholar
• Turcot V, Lu Y, Highland HM, et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018;50:26–41. doi:10.1038/s41588-017-0011-x
   PubMed Web of Science ®Google Scholar
• Yengo L, Sidorenko J, Kemper KE, et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum Mol Genet. 2018;27(20):3641–3649. doi:10.1093/hmg/ddy271
   PubMed Web of Science ®Google Scholar
• Hoffmann TJ, Choquet H, Yin J, et al. A large multiethnic genome-wide association study of adult body mass index identifies novel loci. Genetics. 2018;210:499–515.
   PubMed Web of Science ®Google Scholar
• Loos RJF, Janssens ACJW. Predicting polygenic obesity using genetic information. Cell Metab. 2017;25:535–543. doi:10.1016/j.cmet.2017.02.013
   PubMed Web of Science ®Google Scholar
• Riveros-McKay F, Mistry V, Bounds R, et al. Genetic architecture of human thinness compared to severe obesity. PLoS Genet. 2019;15:e1007603. doi:10.1371/journal.pgen.1007603
   Web of Science ®Google Scholar
• Orthofer M, Valsesia A, Mägi R, et al. Identification of ALK in thinness. Cell. 2020;181:1246–1262.e22. doi:10.1016/j.cell.2020.04.034
   Web of Science ®Google Scholar
• Akbari P, Gilani A, Sosina O, et al. Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity. Science. 2021;373:eabf8683. doi:10.1126/science.abf8683
   Web of Science ®Google Scholar
• Zambrowicz BP, Sands AT. Knockouts model the 100 best-selling drugs – will they model the next 100? Nat Rev Drug Discov. 2003;2:38–51. doi:10.1038/nrd987
   PubMed Web of Science ®Google Scholar
• Walke DW, Han C, Shaw J, Wann E, Zambrowicz B, Sands A. In vivo drug target discovery: identifying the best targets from the genome. Curr Opin Biotechnol. 2001;12:626–631. doi:10.1016/S0958-1669(01)00271-3
   PubMed Web of Science ®Google Scholar
• Hopkins AL, Groom CR. The druggable genome. Nature Rev Drug Discov. 2002;1:727–730. doi:10.1038/nrd892
   PubMed Web of Science ®Google Scholar
• Zheng CJ, Han LY, Yap CW, Ji ZL, Cao ZW, Chen YZ. Therapeutic targets: progress of their exploration and investigation of their characteristics. Pharmacol Rev. 2006;58:259–279. doi:10.1124/pr.58.2.4
   PubMed Web of Science ®Google Scholar
• Landry Y, Gies JP, Drugs and their molecular targets: an updated overview. Fundam Clin Pharmacol. 2008;22:1–18. doi:10.1111/j.1472-8206.2007.00548.x
   Web of Science ®Google Scholar
• Brommage R, Desai U, Revelli JP, et al. High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes. Obesity. 2008;16:2362–2367.
   PubMed Web of Science ®Google Scholar
• Donoviel DB, Freed DD, Vogel OH, et al. Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol. 2001;21:4829–4836. doi:10.1128/MCB.21.14.4829-4836.2001
   PubMed Web of Science ®Google Scholar
• Powell DR, DaCosta C, Gay J, et al. Improved glycemic control in mice lacking Sglt1 and Sglt2. Am J Physiol Endocrinol Metab. 2013;304:E117–E130. doi:10.1152/ajpendo.00439.2012
   PubMed Web of Science ®Google Scholar
• Beltrandelrio H, Kern F, Lanthorn T, et al. Saturation screening of the druggable mammalian genome. In: Carroll PM, Fitzgerald K, editors. Model Organisms in Drug Discovery. Chichester: Wiley & Sons; 2003:251–278.
   Google Scholar
• Brommage R, Liu J, Hansen GM, et al. High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res. 2014;2:14034. doi:10.1038/boneres.2014.34
   PubMed Web of Science ®Google Scholar
• Wattler S, Kelly M, Nehls M. Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques. 1999;26:1150–1160. doi:10.2144/99266rr02
   PubMed Web of Science ®Google Scholar
• Zambrowicz BP, Abuin A, Ramirez-Solis R, et al. Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci USA. 2003;100:14109–14114. doi:10.1073/pnas.2336103100
   PubMed Web of Science ®Google Scholar
• Zambrowicz BP, Holt KH, Walke DW, Kirkpatrick LL, Eberhart DE. Generation of transgenic animals. Target Validation Drug Discovery. 2006:3–26. doi:10.1016/B978-012369393-8/50002-X
   Google Scholar
• Zhang W, Rajan I, Savelieva KV, et al. Netrin-G2 and netrin-G2 ligand are both required for normal auditory responsiveness. Genes Brain Behav. 2008;7:385–392. doi:10.1111/j.1601-183X.2007.00361.x
   Web of Science ®Google Scholar
• Brommage R, Powell DR, Vogel P. Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns. Dis Model Mech. 2019;12:dmm038224. doi:10.1242/dmm.038224
   PubMed Web of Science ®Google Scholar
• Revelli JP, Smith D, Allen J, et al. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity. 2011;19:1010–1018. doi:10.1038/oby.2010.282
   PubMed Web of Science ®Google Scholar
• Powell DR, Doree DD, DaCosta CM, et al. Obesity of G2e3 knockout mice suggests that obesity-associated variants near human G2E3 decrease G2E3 activity. Diabetes Metab Syndr Obes. 2020;13:2641–2652. doi:10.2147/DMSO.S259546
   PubMed Web of Science ®Google Scholar
• Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086–1096. doi:10.1016/0026-0495(79)90146-x
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470. doi:10.2337/diacare.22.9.1462
   PubMed Web of Science ®Google Scholar
• Speakman JR. Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerations. Front Physiol. 2013;4:34. doi:10.3389/fphys.2013.00034
   PubMed Web of Science ®Google Scholar
• Powell DR, Gay J, Wilganowski N, et al. Fads1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque. Diabetes Metab Syndr Obes. 2016;9:185–199. doi:10.2147/DMSO.S106653
   PubMed Web of Science ®Google Scholar
• Powell DR, Gay JP, Wilganowski N, et al. Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice. Front Endocrinol (Lausanne). 2015;6:86. doi:10.3389/fendo.2015.00086
   Web of Science ®Google Scholar
• Speakman JR, O’Rahilly S. Fat: an evolving issue. Dis Model Mech. 2012;5:569–573. doi:10.1242/dmm.010553
   PubMed Web of Science ®Google Scholar
• Vassilatis DK, Hohmann JG, Zeng H, et al. The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA. 2003;100:4903–4908. doi:10.1073/pnas.0230374100
   PubMed Web of Science ®Google Scholar
• Van Gaal L, Pi-Sunyer X, Després JP, McCarthy C, Scheen A. Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program. Diabetes Care. 2008;31(Suppl 2):S229–240. doi:10.2337/dc08-s258
   Web of Science ®Google Scholar
• Van Gaal LF, Scheen AJ, Rissanen AM, Rössner S, Hanotin C, Ziegler O, RIO-Europe Study Group. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study. Eur Heart J. 2008;29:1761–1771. doi:10.1093/eurheartj/ehn076
   PubMed Web of Science ®Google Scholar
• Moreira FA, Crippa JA. The psychiatric side-effects of rimonabant. Braz J Psychiatry. 2009;31:145–153. doi:10.1590/s1516-44462009000200012
   PubMed Web of Science ®Google Scholar
• Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord. 2004;28:640–648. doi:10.1038/sj.ijo.0802583
   PubMed Web of Science ®Google Scholar
• Kyle UG, Shekerdemian LS, Coss-Bu JA. Growth failure and nutrition considerations in chronic childhood wasting diseases. Nutr Clin Pract. 2015;30:227–238. doi:10.1177/0884533614555234
   Web of Science ®Google Scholar
• Southern C, Cook JM, Neetoo-Isseljee Z, et al. Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptors. J Biomol Screen. 2013;18:599–609. doi:10.1177/1087057113475480
   PubMedGoogle Scholar
• Iyinikkel RJ. Identifying Novel G Protein-Coupled Receptor Targets in Pulmonary Arterial Hypertension: Uncovering the Role of GPR75 [PhD thesis]. University of Aberdeen School of Medicine; 2018.
   Google Scholar
• Lu S, Jang W, Inoue A, Lambert NA. Constitutive G protein coupling profiles of understudied orphan GPCRs. PLoS One. 2021;16:e0247743. doi:10.1371/journal.pone.0247743
   Web of Science ®Google Scholar